M & As this week: Epiva Biosciences, Nichi-iko Pharma, Cell Medica

Immunobiotic therapeutics developer Epiva Biosciences has merged with immune-microbiome company Evelo Biosciences to develop new therapeutics for cancer, autoimmune and inflammatory diseases.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news